A new drug to potentially treat depression and neurodegenerative diseases, such as dementia or Parkinson’s, is being ...
New research suggests that the risk for developing dementia is significantly higher than previously estimated, and the burden ...
Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...
Older studies estimated a lower risk of dementia. According to new research, the number of people living with the disease in ...
The findings highlight the need for public-health strategies aimed at mitigating dementia risk and promoting healthy aging across diverse populations, researchers said. “I think ...
This class of drugs was associated with a 20% lower risk of dementia compared to another diabetes medication known as dipeptidyl peptidase-4 (DPP4) inhibitors. SGLT2 inhibitors help lower blood ...
Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...
An estimated 50m people live with dementia globally, more than two-thirds of them in low- and middle-income countries. In 2024, the first drugs that can change the course of Alzheimer’s disease ...
Axovant has axed development of its key dementia drug intepirdine after results suggested it actually worsened symptoms compared with placebo. The news sent the neurology-focused Swiss biotech’s ...
Nov. 19, 2024 — Common cardiovascular drugs are linked to a lower risk of dementia in older age, according to a new ... Earlier Diabetes Diagnosis Linked to Dementia Risk Nov. 19, 2024 ...
Dementia with Lewy bodies (DLB) may not be as well-known as other forms like Alzheimer’s, but is just as devastating, so the discovery that commonly used drugs may reduce the risk of the disease ...